H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia (V体育官网)
- PMID: 19261609
- PMCID: PMC2670165
- DOI: 10.1074/jbc.M808026200
H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia
"V体育ios版" Abstract
Although there is a growing recognition of the significance of hydrogen sulfide (H(2)S) as a biological signaling molecule involved in vascular and nervous system functions, its biogenesis and regulation are poorly understood. It is widely assumed that desulfhydration of cysteine is the major source of H(2)S in mammals and is catalyzed by the transsulfuration pathway enzymes, cystathionine beta-synthase and cystathionine gamma-lyase (CSE). In this study, we demonstrate that the profligacy of human CSE results in a variety of reactions that generate H(2)S from cysteine and homocysteine. The gamma-replacement reaction, which condenses two molecules of homocysteine, yields H(2)S and a novel biomarker, homolanthionine, which has been reported in urine of homocystinuric patients, whereas a beta-replacement reaction, which condenses two molecules of cysteine, generates lanthionine VSports手机版. Kinetic simulations at physiologically relevant concentrations of cysteine and homocysteine, reveal that the alpha,beta-elimination of cysteine accounts for approximately 70% of H(2)S generation. However, the relative importance of homocysteine-derived H(2)S increases progressively with the grade of hyperhomocysteinemia, and under conditions of severely elevated homocysteine (200 microm), the alpha,gamma-elimination and gamma-replacement reactions of homocysteine together are predicted to account for approximately 90% of H(2)S generation by CSE. Excessive H(2)S production in hyperhomocysteinemia may contribute to the associated cardiovascular pathology. .
V体育官网 - Figures







References
-
- Wang, R. (2002) FASEB J. 16 1792-1798 - "VSports" PubMed
-
- Szabo, C. (2007) Nat. Rev. Drug Discov. 6 917-935 - "V体育ios版" PubMed
-
- Li, L., Bhatia, M., and Moore, P. K. (2006) Curr. Opin. Pharmacol. 6 125-129 - PubMed
-
- Goodwin, L. R., Francom, D., Dieken, F. P., Taylor, J. D., Warenycia, M. W., Reiffenstein, R. J., and Dowling, G. (1989) J. Anal. Toxicol. 13 105-109 - PubMed
-
- Abe, K., and Kimura, H. (1996) J. Neurosci. 16 1066-1071 - "VSports最新版本" PMC - PubMed
Publication types
- Actions (V体育2025版)
MeSH terms
- Actions (VSports注册入口)
- "V体育安卓版" Actions
- Actions (V体育2025版)
- VSports在线直播 - Actions
- "VSports app下载" Actions
- V体育官网入口 - Actions
- Actions (V体育官网)
- Actions (V体育官网入口)
- Actions (V体育ios版)
- Actions (V体育ios版)
- "VSports手机版" Actions
- VSports - Actions
- Actions (VSports app下载)
Substances
- "VSports" Actions
- "V体育平台登录" Actions
- Actions (VSports在线直播)
- V体育官网入口 - Actions
- Actions (V体育官网)
V体育2025版 - Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases